Heart failure across Asia: Same healthcare burden but differences in organization of care
© 2016 The Authors A gap in the knowledge on the status of heart failure (HF) in Asia versus other regions led to the creation of a working group of Asian experts from 9 countries or regions (Hong Kong, Indonesia, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam). Each ex...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84981731619&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41342 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
id |
th-cmuir.6653943832-41342 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-413422017-09-28T04:20:41Z Heart failure across Asia: Same healthcare burden but differences in organization of care Reyes E. Ha J. Firdaus I. Ghazi A. Phrommintikul A. Sim D. Vu Q. Siu C. Yin W. Cowie M. © 2016 The Authors A gap in the knowledge on the status of heart failure (HF) in Asia versus other regions led to the creation of a working group of Asian experts from 9 countries or regions (Hong Kong, Indonesia, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam). Each expert sought the best available data from local publications, registries, or clinical practice. The prevalence of HF in Asia was generally similar to global values (1% to 3%), but with some outliers. There were substantial variations in healthcare spending, and the average cost of HF hospitalization varied from 813 US$ in Indonesia to nearly 9000 US$ in South Korea. Comorbidities were frequent, particularly hypertension, diabetes mellitus, and dyslipidemia. Modifiable risk factors such as smoking were alarmingly common in some countries. Asian HF patients spent between 5 and 12.5 days in hospital, and 3% to 15% were readmitted for HF by 30 days. The pharmacological treatment of Asian patients generally followed international guidelines, including renin–angiotensin–aldosterone system inhibitors (61% to 90%), diuretics (76% to 99%), beta-blockers (32% to 78%), and digoxin (19% to 53%), with some room for improvement in terms of life-saving therapies. Our review supports implementation of a more comprehensive and organized approach to HF care in Asia. 2017-09-28T04:20:41Z 2017-09-28T04:20:41Z 2016-11-15 Journal 01675273 2-s2.0-84981731619 10.1016/j.ijcard.2016.07.256 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84981731619&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41342 |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
description |
© 2016 The Authors A gap in the knowledge on the status of heart failure (HF) in Asia versus other regions led to the creation of a working group of Asian experts from 9 countries or regions (Hong Kong, Indonesia, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam). Each expert sought the best available data from local publications, registries, or clinical practice. The prevalence of HF in Asia was generally similar to global values (1% to 3%), but with some outliers. There were substantial variations in healthcare spending, and the average cost of HF hospitalization varied from 813 US$ in Indonesia to nearly 9000 US$ in South Korea. Comorbidities were frequent, particularly hypertension, diabetes mellitus, and dyslipidemia. Modifiable risk factors such as smoking were alarmingly common in some countries. Asian HF patients spent between 5 and 12.5 days in hospital, and 3% to 15% were readmitted for HF by 30 days. The pharmacological treatment of Asian patients generally followed international guidelines, including renin–angiotensin–aldosterone system inhibitors (61% to 90%), diuretics (76% to 99%), beta-blockers (32% to 78%), and digoxin (19% to 53%), with some room for improvement in terms of life-saving therapies. Our review supports implementation of a more comprehensive and organized approach to HF care in Asia. |
format |
Journal |
author |
Reyes E. Ha J. Firdaus I. Ghazi A. Phrommintikul A. Sim D. Vu Q. Siu C. Yin W. Cowie M. |
spellingShingle |
Reyes E. Ha J. Firdaus I. Ghazi A. Phrommintikul A. Sim D. Vu Q. Siu C. Yin W. Cowie M. Heart failure across Asia: Same healthcare burden but differences in organization of care |
author_facet |
Reyes E. Ha J. Firdaus I. Ghazi A. Phrommintikul A. Sim D. Vu Q. Siu C. Yin W. Cowie M. |
author_sort |
Reyes E. |
title |
Heart failure across Asia: Same healthcare burden but differences in organization of care |
title_short |
Heart failure across Asia: Same healthcare burden but differences in organization of care |
title_full |
Heart failure across Asia: Same healthcare burden but differences in organization of care |
title_fullStr |
Heart failure across Asia: Same healthcare burden but differences in organization of care |
title_full_unstemmed |
Heart failure across Asia: Same healthcare burden but differences in organization of care |
title_sort |
heart failure across asia: same healthcare burden but differences in organization of care |
publishDate |
2017 |
url |
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84981731619&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41342 |
_version_ |
1681421984429244416 |